Publications by authors named "Ingrid Desar"

Claim this Profile
H
Health-related quality of life in patients with advanced soft tissue sarcoma receiving first-line palliative chemotherapy (HOLISTIC): longitudinal results from a prospective, observational cohort study.
Evelyne Roets, Eugenie Younger, Robin L Jones, Dide den Hollander, Leyla Azarang, Ingrid M E Desar

EClinicalMedicine· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Substitution of ifosfamide for cyclophosphamide in the TI-CE regimen: pharmacology and dose justification in a patient with refractory metastatic germ-cell tumor post-nephrectomy-A case report.
Lotte M G Hulskotte, Loek A W de Jong, Alwin D R Huitema, Joost Sijm, Ingrid Desar

Cancer Chemother Pharmacol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing Safety of the Transition to Generic Imatinib in Patients with Gastrointestinal Stromal Tumours.
Joris M van Sabben, Maud B A van der Kleij, Evelyne Roets, Renaud L M Tissier, Dorieke E M van Balen, Ingrid M E Desar

Oncol Ther· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cemiplimab in Locally Advanced or Metastatic Secondary Angiosarcomas (CEMangio): A Phase II Clinical Trial and Biomarker Analyses.
Stefan G van Ravensteijn, Jacco J de Haan, Hans Gelderblom, Maikel J L Nederkoorn, Melissa H S Hillebrandt-Roeffen, Ingrid M E Desar

Clin Cancer Res· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Author Correction: Establishment and characterization of the first patient-derived radiation-induced angiosarcoma xenograft model (RT-AS5).
Yvonne M H Versleijen-Jonkers, Melissa H S Hillebrandt-Roeffen, Marije E Weidema, Jeroen Mooren, Daniel T von Rhein, Ingrid M E Desar

Sci Rep· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Explaining needs for rehabilitation in patients with bone sarcoma and a megaprosthesis: a qualitative, grounded theory study.
Jorinde Jpm Denissen, Ingrid Cm van der Geest, Gerben van Hinte, Ingrid Me Desar, Philip J van der Wees

Disabil Rehabil· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploring the contribution of genetic variants to high sunitinib exposure in patients with cancer.
Eline L Giraud, Stefanie D Krens, Stefan Böhringer, Ingrid M E Desar, Sita H Vermeulen

Br J Clin Pharmacol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Mutation Profile on Outcomes of Neoadjuvant Therapy in GIST.
Mahmoud Mohammadi, Evelyne Roets, Roos F Bleckman, Astrid W Oosten, Dirk Grunhagen, Ingrid M E Desar

Cancers (Basel)· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetic exposure and treatment outcomes of lenvatinib in patients with renal cell carcinoma and differentiated thyroid carcinoma.
Marinda Meertens, Eline L Giraud, Esbar Hassan, Sybrand W J Zielhuis, Tiemen T Snels, Ingrid M E Desar

Cancer Chemother Pharmacol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Levels of circulating tumor DNA correlate with tumor volume in gastro-intestinal stromal tumors: an exploratory long-term follow-up study.
Roos F Bleckman, Charlotte M S C Haag, Naomi Rifaela, Gerrieke Beukema, Ron H J Mathijssen, Ingrid M E Desar

Mol Oncol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic drug monitoring in anticancer agents: perspectives of Australian medical oncologists.
Alexandra Flynn, Peter Galettis, Howard Gurney, Michael Michael, Ingrid Desar

Intern Med J· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reasons for non-feasibility of therapeutic drug monitoring of oral targeted therapies in oncology - an analysis of the closed cohorts of a multicentre prospective study.
Maud B A van der Kleij, Niels A D Guchelaar, Marinda Meertens, Kim Westerdijk, Eline L Giraud, Ingrid M E Desar

Br J Cancer· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluating the Clinical Impact and Feasibility of Therapeutic Drug Monitoring of Pazopanib in a Real-World Soft-Tissue Sarcoma Cohort.
Marinda Meertens, Eline L Giraud, Maud B A van der Kleij, Kim Westerdijk, Niels A D Guchelaar, Ingrid M E Desar

Clin Pharmacokinet· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Financial difficulties experienced by patients with gastrointestinal stromal tumours (GIST) in the Netherlands: data from a cross-sectional multicentre study.
Deborah van de Wal, Dide den Hollander, Ingrid M E Desar, Hans Gelderblom, Astrid W Oosten

Support Care Cancer· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Individualized Dosing Patterns in the Treatment of Older Patients with Gastrointestinal Stromal Tumors: Results of a Registry-Based Observational National Cohort Study Including 871 Patients.
Roos F Bleckman, K Esther Broekman, Evelyne Roets, Mohammed Mohammadi, Ingrid M E Desar

Drugs Aging· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Referral patterns of GIST patients: data from a nationwide study.
Evelyne Roets, Nikki S Ijzerman, Vincent K Y Ho, Ingrid M E Desar, Anna K L Reyners

Acta Oncol· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Results of the first international quality control programme for oral targeted oncolytics.
Eline L Giraud, Lindsey M H Te Brake, Erik C A van den Hombergh, Ingrid M E Desar, Dina M Kweekel

Br J Clin Pharmacol· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of Aprepitant on Etoposide Pharmacokinetics in Patients with Testicular Cancer: A Pharmacokinetic Study to Determine the Absence of a Clinically Relevant Interaction.
Jeffrey Strik, Loek A W de Jong, Joost Sijm, Ingrid M E Desar, Nielka P van Erp

Clin Pharmacol Ther· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost Savings and Waste Reduction Through Redispensing Unused Oral Anticancer Drugs: The ROAD Study.
Elisabeth M Smale, Bart J F van den Bemt, Eibert R Heerdink, Ingrid M E Desar, Toine C G Egberts

JAMA Oncol· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fear, anxiety and depression in gastrointestinal stromal tumor (GIST) patients in the Netherlands: Data from a cross-sectional multicenter study.
Deborah van de Wal, Dide den Hollander, Ingrid M E Desar, Hans Gelderblom, Astrid W Oosten

Int J Clin Health Psychol· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The association of having a monitoring or blunting coping style with psychological distress, health-related quality of life and satisfaction with healthcare in gastrointestinal stromal tumour (GIST) patients.
Deborah van de Wal, Britt van Doorn, Dide den Hollander, Ingrid M E Desar, Hans Gelderblom

Acta Oncol· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic drug monitoring to personalize dosing of imatinib, sunitinib, and pazopanib: A mixed methods study on barriers and facilitators.
Kim Westerdijk, Neeltje Steeghs, Casper S J Tacke, Winette T A van der Graaf, Nielka P van Erp, Ingrid M E Desar

Cancer Med· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Personalized Therapy of Sarcomas.
Ingrid M E Desar, Christian Rothermundt

Cancers (Basel)· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic Factors in Epithelioid Hemangioendothelioma: Analysis of a Nationwide Molecularly/Immunohistochemically Confirmed Cohort of 57 Cases.
Tess Tomassen, Yvonne M H Versleijen-Jonkers, Melissa H S Hillebrandt-Roeffen, Patricia H J Van Cleef, Thijs van Dalen, Ingrid M E Desar

Cancers (Basel)· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Prognostic Relevance of MRI Characteristics in Myxofibrosarcoma Patients Treated with Neoadjuvant Radiotherapy.
Stefan G van Ravensteijn, Maikel J L Nederkoorn, Tom C P Wal, Yvonne M H Versleijen-Jonkers, Pètra M Braam, Ingrid M E Desar

Cancers (Basel)· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis